Marie L Tørring1, Alina Z Falborg2, Henry Jensen2, Richard D Neal3, David Weller4, Irene Reguilon5, Usha Menon6, Peter Vedsted2. 1. Department of Anthropology, School of Culture and Society, Aarhus University, Højbjerg, Denmark. 2. Research Unit for General Practice, Research Centre for Cancer Diagnosis in Primary Care, Aarhus C, Denmark. 3. Academic Unit of Primary Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. 4. Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK. 5. International Cancer Benchmarking Partnership, London, UK. 6. Gynaecological Cancer Research Centre, Institute for Women's Health, University College London, London, UK.
Abstract
OBJECTIVE: To investigate the relationship between tumour stage at diagnosis and selected components of primary and secondary care in the diagnostic interval for breast, colorectal, lung and ovarian cancers. METHODS: Observational study based on data from 6,162 newly diagnosed symptomatic cancer patients from Module 4 of the International Cancer Benchmarking Partnership. We analysed the odds of advanced stage of cancer as a flexible function of the length of primary care interval (days from first presentation to referral) and secondary care interval (days from referral to diagnosis), respectively, using logistic regression with restricted cubic splines. RESULTS: The association between time intervals and stage was similar for each type of cancer. A statistically significant U-shaped association was seen between the secondary care interval and the diagnosis of advanced rather than localised cancer, odds decreasing from the first day onwards and increasing around three and a half months. A different pattern was seen for the primary care interval, flat trends for colorectal and lung cancers and a slightly curved association for ovarian cancer, although not statistically significant. CONCLUSION: The results confirm previous findings that some cancers may progress even within the relatively short time frame of regulated diagnostic intervals. The study supports the current emphasis on expediting symptomatic diagnosis of cancer.
OBJECTIVE: To investigate the relationship between tumour stage at diagnosis and selected components of primary and secondary care in the diagnostic interval for breast, colorectal, lung and ovarian cancers. METHODS: Observational study based on data from 6,162 newly diagnosed symptomatic cancerpatients from Module 4 of the International Cancer Benchmarking Partnership. We analysed the odds of advanced stage of cancer as a flexible function of the length of primary care interval (days from first presentation to referral) and secondary care interval (days from referral to diagnosis), respectively, using logistic regression with restricted cubic splines. RESULTS: The association between time intervals and stage was similar for each type of cancer. A statistically significant U-shaped association was seen between the secondary care interval and the diagnosis of advanced rather than localised cancer, odds decreasing from the first day onwards and increasing around three and a half months. A different pattern was seen for the primary care interval, flat trends for colorectal and lung cancers and a slightly curved association for ovarian cancer, although not statistically significant. CONCLUSION: The results confirm previous findings that some cancers may progress even within the relatively short time frame of regulated diagnostic intervals. The study supports the current emphasis on expediting symptomatic diagnosis of cancer.
Keywords:
bias; breast neoplasms; colorectal neoplasms; delayed diagnosis; diagnosis; early detection of cancer; lung neoplasms; ovarian neoplasms; primary health care; time factors; waiting lists
Authors: Minjoung M Koo; Georgios Lyratzopoulos; Annie Herbert; Gary A Abel; Rachel M Taylor; Julie A Barber; Faith Gibson; Jeremy Whelan; Lorna A Fern Journal: JAMA Netw Open Date: 2020-09-01
Authors: N F van Erp; C W Helsper; P Slottje; D Brandenbarg; F L Büchner; K M van Asselt; Jwm Muris; M F Kortekaas; Phm Peeters; N J de Wit Journal: United European Gastroenterol J Date: 2020-04-06 Impact factor: 4.623
Authors: Charlotte Lynch; Irene Reguilon; Deanna L Langer; Damon Lane; Prithwish De; Wai-Lup Wong; Fergus Mckiddie; Andrew Ross; Lorraine Shack; Thida Win; Christopher Marshall; Mona-Eliszabeth Revheim; Bolette Danckert; John Butler; Sabina Dizdarevic; Cheryl Louzado; Canice Mcgivern; Anne Hazlett; Cindy Chew; Martin O'connell; Samantha Harrison Journal: Int J Qual Health Care Date: 2021-02-20 Impact factor: 2.038
Authors: Koen Degeling; Nancy N Baxter; Jon Emery; Mark A Jenkins; Fanny Franchini; Peter Gibbs; G Bruce Mann; Grant McArthur; Benjamin J Solomon; Maarten J IJzerman Journal: Asia Pac J Clin Oncol Date: 2021-02-10 Impact factor: 1.926
Authors: Sarah Price; Anne Spencer; Xiaohui Zhang; Susan Ball; Georgios Lyratzopoulos; Ruben Mujica-Mota; Sal Stapley; Obioha C Ukoumunne; Willie Hamilton Journal: Cancer Epidemiol Date: 2020-09-09 Impact factor: 2.984